The economic burden of HER2-targeted therapy among metastatic breast cancer patients

被引：1
|
作者：
Forero-Torres, Andres [1 ]
Anupindi, Vamshi Ruthwik [2 ]
Yeaw, Jason [2 ]
DeKoven, Mitch [2 ]
Feliciano, Joseph [1 ]
Richhariya, Akshara [1 ]
机构：
[1] Seattle Genet, Bothell, WA USA
[2] IQVIA, Falls Church, VA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P1-18-17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-18-17
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Detection of HER2-low lesions using HER2-targeted PET imaging in patients with HER2-negative metastatic breast cancer
    Yeh, R.
    Lyashchenko, S. K.
    Zeglis, B. M.
    Lewis, J. S.
    Ulaner, G. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S33 - S33
  • [32] Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
    Rita Nahta
    Dihua Yu
    Mien-Chie Hung
    Gabriel N Hortobagyi
    Francisco J Esteva
    Nature Clinical Practice Oncology, 2006, 3 : 269 - 280
  • [33] HER2-targeted therapies beyond breast cancer - an update
    Yoon, Jeesun
    Oh, Do-Youn
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (09) : 675 - 700
  • [34] HER2-Targeted Therapy for Early-Stage Breast Cancer: A Comprehensive Review
    Brown-Glaberman, Ursa
    Dayao, Zoneddy
    Royce, Melanie
    ONCOLOGY-NEW YORK, 2014, 28 (04): : 281 - 289
  • [35] Cardiac Complications of HER2-Targeted Therapies in Breast Cancer
    Addetia K.
    DeCara J.M.
    Current Treatment Options in Cardiovascular Medicine, 2016, 18 (6)
  • [36] EFFICACY OF HER2-TARGETED THERAPY FOR HER2 POSITIVE BREAST CANCER ACCORDING TO HR STATUS
    Murata, T.
    Takahashi, M.
    Hayashida, T.
    Hirose, S.
    Jinno, H.
    Kitagawa, Y.
    BREAST, 2013, 22 : S104 - S104
  • [37] HER2-targeted therapy is changing
    Matsumura, Noriomi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (04): : 325 - 325
  • [38] HER2-Targeted Therapy in Osteosarcoma
    Gill, Jonathan
    Hingorani, Pooja
    Roth, Michael
    Gorlick, Richard
    CURRENT ADVANCES IN OSTEOSARCOMA: CLINICAL PERSPECTIVES: PAST, PRESENT AND FUTURE, 2ND EDITION, 2020, 1257 : 55 - 66
  • [39] HER2-targeted therapies — a role beyond breast cancer
    Do-Youn Oh
    Yung-Jue Bang
    Nature Reviews Clinical Oncology, 2020, 17 : 33 - 48
  • [40] HER2-targeted therapies - a role beyond breast cancer
    Oh, Do-Youn
    Bang, Yung-Jue
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (01) : 33 - 48
12345